ARTICLES BY BIOPHORUM

• The Process Map To Ensure Biopharma Raw Materials Supply

  8/16/2022

  In new product introduction, there is often a lack of a basic data package for a product being scaled up for clinical or launch supplies. This can lead to several issues, e.g., capacity and lead time restrictions, oversupply, and more. A stepwise process can be used as a guideline for introducing a material to support new drug substance manufacture.